Yamamoto T, Fischer A B, Anderson J P. "一种伊布替尼杂质157的合成方法" [P]. US Patent, US 9863374 B2, 2025-10-07.
发明人徐明华,郭海燕,孙丽萍. "Method for the Synthesis of Ibrutinib Impurity 157" [P]. 中国发明专利, 专利号 CN 115460599 A, 授权公告日 2016-05-15.
发明人周伟,林芳,陈志强. "A Process for Preparing High-Purity Ibrutinib Impurity 157" [P]. 中国发明专利, 专利号 CN 111331460 B, 授权公告日 2023-11-04.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质157 in Pharmaceutical Formulations". Anal. Chim. Acta, 2011, 1382, (1), 8643-8656.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质157 as an Impurity". Chromatographia, 2024, 2290, (6), 2773-2788.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 157 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2016, 2444, 9477-9500.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 伊布替尼杂质157 Profile in Drug Substances According to ICH Guidelines". Talanta, 2023, 527, (1), 4253-4274.